Mucha Paulina, Hikisz Pawel, Gwoździński Krzysztof, Krajewska Urszula, Leniart Andrzej, Budzisz Elzbieta
Department of Cosmetic Raw Materials Chemistry, Faculty of Pharmacy, Medical University of Lodz Ul Muszynskiego 1 90-151 Lodz Poland
Department of Molecular Biophysics, Faculty of Biology and Evironmental Protection, University of Lodz Pomorska 141/143 90-236 Lodz Poland.
RSC Adv. 2019 Oct 8;9(55):31943-31952. doi: 10.1039/c9ra05971g. eCollection 2019 Oct 7.
This paper describes the synthesis of new 6-aminoflavone (6AFl (3)) and 6-aminochromone (6AC (4)) complexes with Cu(ii) and Ru(ii) ions ([Cu(6AC)Cl] (3a), [Cu(6AFl)Cl] (4a), [Ru(-cymene)(6AC)Cl] (4b)) and comparison of their properties with the previously described 7-aminoflavone (7AFl (1)) and 7-amino-2-methylchromone (7A2MC (2)) analogues. The cytotoxic effect of all these complexes against two human leukaemia cell lines (HL-60 and NALM-6), melanoma WM-115 cells and COLO205 cells, is determined. The cytotoxicity of copper(ii) complexes, especially [Cu(6AFl)Cl] (3a) was higher than ruthenium(ii) complexes with the same ligands. Their cytotoxic potency was also stronger in comparison to the referential agents like cisplatin. The pro-oxidative properties were determined for the most active complexes and their ability to generate ROS (reactive oxygen species)/RNS (reactive nitrogen species) in cancer cells was confirmed. The type of ligand and the chemical structure of the tested complexes had an influence on the level of ROS/RNS generated in cancer cells. The redox properties of the copper complex compounds were evaluated by cyclic voltammetry, and compared with the data for Ru(ii) complexes. The reduction and oxidation processes of Ru(iii)/Ru(ii) and Cu(ii)/Cu(i) were described as quasi-reversible.
本文描述了新型6-氨基黄酮(6AFl (3))和6-氨基色酮(6AC (4))与铜(II)和钌(II)离子的配合物([Cu(6AC)Cl] (3a)、[Cu(6AFl)Cl] (4a)、[Ru(-异丙基苯)(6AC)Cl] (4b))的合成,并将它们的性质与先前描述的7-氨基黄酮(7AFl (1))和7-氨基-2-甲基色酮(7A2MC (2))类似物进行了比较。测定了所有这些配合物对两种人类白血病细胞系(HL-60和NALM-6)、黑色素瘤WM-115细胞和COLO205细胞的细胞毒性作用。铜(II)配合物,尤其是[Cu(6AFl)Cl] (3a)的细胞毒性高于具有相同配体的钌(II)配合物。与顺铂等参考药物相比,它们的细胞毒性效力也更强。测定了最具活性的配合物的促氧化性质,并证实了它们在癌细胞中产生ROS(活性氧物种)/RNS(活性氮物种)的能力。配体类型和测试配合物的化学结构对癌细胞中产生的ROS/RNS水平有影响。通过循环伏安法评估了铜配合物的氧化还原性质,并与钌(II)配合物的数据进行了比较。Ru(III)/Ru(II)和Cu(II)/Cu(I)的还原和氧化过程被描述为准可逆的。